Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.4 USD | -0.73% |
|
-1.00% | +131.86% |
12/06 | Vera Therapeutics, Inc. Appoints Christy Oliger to the Board | CI |
28/05 | Vera Therapeutics Gets FDA Breakthrough Therapy Designation for Immunoglobulin A Nephropathy Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+131.86% | 195.06Cr | |
+35.11% | 5.15TCr | |
-6.92% | 3.9TCr | |
+34.92% | 3.89TCr | |
-12.11% | 2.67TCr | |
+12.70% | 2.61TCr | |
-14.72% | 1.99TCr | |
+43.56% | 1.37TCr | |
+30.70% | 1.24TCr | |
-4.15% | 1.17TCr |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Jefferies Downgrades Vera Therapeutics to Hold From Buy, Slashes Price Target to $6 From $32